To assess risk of high BP in pregnant women.
Not Applicable
- Conditions
- Health Condition 1: O14- Pre-eclampsia
- Registration Number
- CTRI/2020/03/023799
- Lead Sponsor
- Kasturba Medical College Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients booked at 12 or less than 12 weeks who underwent NT scan
in Kasturba hospital, Manipal during the study period.
Exclusion Criteria
Patients allergic to aspirin and heart disease complicating pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess risk for pre eclampsia in pregnant women at 12 weeksTimepoint: To assess risk for pre eclampsia in pregnant women at 12 weeks of gestation
- Secondary Outcome Measures
Name Time Method To observe the perinatal outcome in patients having clinical, biochemical and ultrasonological risk factors for pre-eclampsia taking aspirin 75mg at 12 to 16 weeks of gestationTimepoint: After delivery of the patient.